Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06470373
What this trial is testing

Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Rophibio, Inc. 434
Not applicableLooking for participantsNCT02253030
What this trial is testing

OCT Angiography in Wet AMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Oregon Health and Science University 160
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Post-approval studies (Phase 4)Looking for participantsNCT06742307
What this trial is testing

Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration

Who this might be right for
Macular Degeneration Choroidal Neovascularization
Hospital Authority, Hong Kong 40
Large-scale testing (Phase 3)Study completedNCT01948830
What this trial is testing

Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Novartis Pharmaceuticals 650
Large-scale testing (Phase 3)Study completedNCT00061594
What this trial is testing

Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration

Who this might be right for
Macular Degeneration
Genentech, Inc. 426
Large-scale testing (Phase 3)Study completedNCT02434328
What this trial is testing

Efficacy and Safety of RTH258 Versus Aflibercept - Study 2

Who this might be right for
Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
Alcon Research 1,048
Testing effectiveness (Phase 2)Ended earlyNCT02398500
What this trial is testing

Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
Alcon Research 25
Not applicableStudy completedNCT05211804
What this trial is testing

Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse

Who this might be right for
Wet Macular Degeneration
Sorlandet Hospital HF 31
Not applicableStudy completedNCT02420132
What this trial is testing

Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)

Who this might be right for
Macular EdemaMacular Degeneration
Hoffmann-La Roche 47
Testing effectiveness (Phase 2)Study completedNCT01089517
What this trial is testing

A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 449
Early research (Phase 1)Study completedNCT02867735
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 28
Post-approval studies (Phase 4)Ended earlyNCT01983579
What this trial is testing

TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection

Who this might be right for
Neovascular Age Related Macular Degeneration (AMD)Open Angle Glaucoma
Sensimed AG 4
Early research (Phase 1)Study completedNCT02061865
What this trial is testing

Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD

Who this might be right for
Neovascular Wet Age-related Macular Degeneration (AMD)
Regeneron Pharmaceuticals 12
Very early researchLooking for participantsNCT06031727
What this trial is testing

CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)
HuidaGene Therapeutics Co., Ltd. 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07766473
What this trial is testing

First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD)

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Filamon LTD 24
Post-approval studies (Phase 4)Study completedNCT03552770
What this trial is testing

Single or Combined Protocols for NV-AMD

Who this might be right for
Age-Related Macular Degeneration
University Hospital of Ferrara 109
Large-scale testing (Phase 3)Active Not RecruitingNCT06491914
What this trial is testing

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 1,126
Testing effectiveness (Phase 2)Ended earlyNCT04746963
What this trial is testing

Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AsclepiX Therapeutics, Inc. 3
Not applicableStudy completedNCT03939195
What this trial is testing

OCTA (Optical Coherence Angiography Tomography) Versus Structural OCT(Optical Coherence Tomography) in Neovascular AMD (Age Macular Degeneration)

Who this might be right for
Macular Degeneration Exudative Eye LeftMacular Degeneration Exudative Eye Right
Centre Hospitalier Intercommunal Creteil 130
Next Page